XML 13 R39.htm IDEA: XBRL DOCUMENT

Share-Based Compensation Plans (Tables)

3 Months Ended

Mar. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The following table summarizes the new grants issued during the three months ended March 31, 2013:



Grant date	Restricted stock	Grant date fair value of restricted stock		Stock options	Grant date fair value of stock options		Performance shares	Grant date fair value of performance shares
January 2, 2013	1,805	$	25.20	—	$	—	—	$	—
January 22, 2013	47,994	$	23.90	77,715	$	14.77	95,991	$	27.41
February 4, 2013	18,668	$	22.63	17,692	$	14.00	21,828	$	25.96

Summary of stock option and SAR's activity

The following options and stock appreciation rights were exercised during the three months ended March 31, 2013:



Award Type	Number of Units	Weighted Average Exercise Price
Options	926	$	20.80
Stock Appreciation Rights	3,846	$	15.40

Weighted average fair value of SAR's, performance units and RSU's outstanding

The following shows the weighted average fair value of SARs outstanding at March 31, 2013:



	SARs
Weighted average fair value	$	8.11

Options and SAR's exercisable

The following table shows the options and SARs exercisable at March 31, 2013:



Options Exercisable	Weighted Average Exercise Price		SARs Exercisable	Weighted Average Exercise Price
252,171	$	33.15	65,019	$	14.21

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details